57,725
Participants
Start Date
January 31, 2008
Primary Completion Date
September 30, 2015
Study Completion Date
February 28, 2019
filgrastim, TBO-filgrastim or pegfilgrastim
First cycle
Collaborators (2)
Henry Ford Health System
OTHER
Aetna, Inc.
INDUSTRY
Amgen
INDUSTRY
College of Pharmacy, University of Nebraska College
UNKNOWN
College of Pharmacy, University of New England
UNKNOWN
HealthPartners Institute
OTHER
Momenta Pharmaceuticals, Inc.
INDUSTRY
Harvard Pilgrim Health Care
OTHER
Biologics & Biosimilars Collective Intelligence Consortium
OTHER